Kaohsiung, Taiwan

Chun-Yu Lin

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Chun-Yu Lin

Introduction

Chun-Yu Lin is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medical and technological innovations. With a total of 2 patents, his work focuses on addressing critical health issues and improving device fabrication processes.

Latest Patents

Chun-Yu Lin's latest patents include a method for treating subjects suffering from flavivirus infection. This invention discloses a method that involves administering a pharmaceutical composition containing a pharmaceutically effective amount of an anti-CD44 antibody. Another significant patent is a method for establishing a scattering bar rule for a mask pattern used in device fabrication. This method includes establishing an image simulation model based on the mask pattern and applying various scattering bar reference sets to generate simulation images, ultimately leading to the determination of a pattern layout.

Career Highlights

Throughout his career, Chun-Yu Lin has worked with esteemed institutions such as Kaohsiung Medical University and Promos Technologies, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Chun-Yu Lin has collaborated with notable colleagues, including Yen-Hsu Chen and Paraskevi Heldin. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Chun-Yu Lin's contributions to innovation in medical treatments and device fabrication highlight his role as a significant inventor. His patents reflect a commitment to improving health outcomes and advancing technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…